These Were the 2 Worst-Performing Stocks in the S&P 500...
The S&P 500 rebounded in May, but some stocks crashed on company-specific concerns. While one healthcare giant withdrew its outlook for 2025, another faced an unexpected setback in a drug...
Tag: Regeneron Pharmaceuticals
3 results found
23andMe’s founder Anne Wojcicki wins bid for bankrupt DNA testing...
By Siddhi Mahatole and Mariam Sunny (Reuters) -Anne Wojcicki is set to regain control of 23andMe after a $305 million bid from a nonprofit she controls topped Regeneron Pharmaceuticals’ offer...
JPMorgan Calls the Selloff Excessive, Trims Regeneron Pharmaceuticals, Inc. (REGN)...
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of the 13 Biotech Stocks with Huge Upside Potential. JPMorgan has maintained its Overweight rating on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) after reducing its price...
